tions (39%, compared to an average of 26.2% for outbreaks of Heidelberg infections) have raised questions concerning whether the severity of this outbreak was due to pathogen dose or if this multidrug-resistant outbreak "strain" was novel (11) . While theses isolates do not match previously studied Heidelberg isolates in our laboratory by PFGE, resistance gene content, and plasmid type, NARMS has identified several isolates from past routine surveillance of isolates from ground turkey, turkey, and human clinical samples that match the observed characteristics, including XbaI PFGE pattern, AST pattern, and plasmid characteristics (AR genes, Inc type, ST, and size) (7, 13) .
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